echoloc/ Companies/ Prothya Biosolutions

Company profile

Prothya Biosolutions Tech Stack

Plasma fractionation and plasma-derived protein therapy manufacturing

Pharmaceutical Manufacturing Neder-Over-Heembeek, Brussels 1,001–5,000 employees Founded 2021 Privately Held

Prothya Biosolutions fractionates human plasma into clotting factors, immunoglobulins and albumin for international pharma partners. Its stack pairs a deep OT layer (SCADA, Siemens TIA Portal, Wonderware, Ignition, DCS, MES) with a Microsoft data platform (Fabric, Synapse, Data Factory, Power BI), pointing to plant-floor data modernization. Hiring is accelerating and engineering-led, with GMP compliance and equipment reliability as recurring pressures.

Tech Stack 36 technologies

Core StackPower BI Azure Data Factory SQL Server Python Apache Spark SAP Siemens Microsoft Fabric Azure Synapse HPLC GCP SCADA Siemens Step 7 TIA Portal Wonderware Ignition CMMS SAP PM DCS HMI SAP WM Minitab MES Microsoft Access PLCs HMIS ABB Rockwell Automation Structured Text Modbus+6 more

What Prothya Biosolutions Is BuildingChallenges and projects from their job posts

◆Challenges

Maintaining GMP compliance across manufacturing
Equipment failures and recurring production issues
Information security and incident response across locations
Budget management for engineering projects
Reducing process risk and optimizing manufacturing

▲Active Projects

Future-proof manufacturing systems development and investments
Post-acquisition finance transition
Validation of EM and UM methods
Multidisciplinary engineering projects
Continuous improvement of EM and UM processes

Hiring Activity

Accelerating25 roles · 15 in 30d

Department

Engineering

Manufacturing

Quality

Ops

Finance

Security

Seniority

Senior

Mid

Junior

Manager

Lead

Companies like Prothya Biosolutions

100+ Pharmaceutical Manufacturing companies running Power BI and SQL Server

See the full list

About Prothya Biosolutions

Prothya Biosolutions is a Brussels-headquartered plasma fractionation company formed in 2021 through the integration of Plasma Industries Belgium and Sanquin Plasma Products. It produces plasma-derived medicinal products, including clotting factors, immunoglobulins and albumin solutions, for international pharmaceutical partners. The company processes roughly 3 million liters of plasma per year and employs between 1,001 and 5,000 people. Operations run on SAP modules for maintenance and warehousing alongside industrial automation from Siemens, ABB and Rockwell Automation. Current hiring spans the Netherlands, Canada and Peru.

HeadquartersNeder-Over-Heembeek, Brussels

Company Size1,001–5,000 employees

Founded2021

Hiring MarketsNetherlands, Canada, Peru

Frequently Asked Questions

What tech stack does Prothya Biosolutions use?

Prothya uses Microsoft Fabric, Azure Synapse, Azure Data Factory, Power BI and SQL Server for data, SAP PM and SAP WM for operations, and SCADA, MES, DCS, Siemens TIA Portal and Wonderware on the plant floor.

Is Prothya Biosolutions hiring engineers?

Yes. Hiring is accelerating and led by engineering, followed by manufacturing and quality roles, with a skew toward senior-level positions in the Netherlands, Canada and Peru.

Where is Prothya Biosolutions headquartered?

Prothya Biosolutions is headquartered in Neder-Over-Heembeek, Brussels, Belgium, and was founded in 2021.

Similar Companies in Pharmaceutical Manufacturing

Other companies in the same industry, closest in size

Simtra BioPharma Solutions

Pharmaceutical Manufacturing

Jubilant Pharma Limited

Pharmaceutical Manufacturing

Polpharma

Pharmaceutical Manufacturing

Par Health

Pharmaceutical Manufacturing

How this profile is built

Prothya Biosolutions's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.